An Ongoing Phase 1/2a Study of ABT-263; Pharmacokinetics (PK), Safety and Anti-Tumor Activity in Patients (pts) with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Author(s)
- Roberts, AW; Seymour, JF; Brown, JR; Wierda, WG; Kipps, TJ; Carney, D; Xiong, H; Cui, Y; Busman, T; Enschede, S; Krivoshik, A; Humerickhouse, R;
- Details
- Publication Year 2009-11-20,Volume 114,Issue #22,Page 364-364
- Journal Title
- BLOOD
- Publication Type
- Journal Article
- Publisher
- AMER SOC HEMATOLOGY
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2009-11-20 12:00:00